PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 126 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,031,000 | +40.8% | 232,128 | +73.3% | 0.06% | +60.0% |
| Q3 2019 | $1,442,000 | +470.0% | 133,969 | +571.8% | 0.04% | +600.0% |
| Q2 2019 | $253,000 | -62.5% | 19,943 | +14.6% | 0.01% | -66.7% |
| Q1 2019 | $675,000 | +36.6% | 17,400 | +249.6% | 0.02% | +36.4% |
| Q4 2017 | $494,000 | -40.0% | 4,977 | -77.5% | 0.01% | -45.0% |
| Q1 2017 | $823,000 | -46.6% | 22,131 | -55.9% | 0.02% | -63.6% |
| Q4 2016 | $1,542,000 | -64.0% | 50,235 | -21.5% | 0.06% | -58.3% |
| Q3 2016 | $4,289,000 | -24.9% | 63,967 | -12.5% | 0.13% | -2.2% |
| Q4 2015 | $5,713,000 | +110.0% | 73,142 | +180.0% | 0.14% | +70.9% |
| Q1 2014 | $2,720,000 | -26.5% | 26,120 | -68.7% | 0.08% | -21.0% |
| Q2 2013 | $3,703,000 | – | 83,458 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |